Medpace (NASDAQ:MEDP) reports bullish Q4 CY2025

view original post

Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q4 CY2025 results , with sales up 32% year on year to $708.5 million. The company expects the full year’s revenue to be around $2.81 …